Diagnosis and Treatment of Helicobacter pylori Infection

YC Lee, MP Dore, DY Graham - Annual review of medicine, 2022 - annualreviews.org
The last 5 years have seen major shifts in defining whom to test and how to treat
Helicobacter pylori infection. Peptic ulcer has changed from a chronic disease to a one-off …

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management

A Nabavi-Rad, A Sadeghi, H Asadzadeh Aghdaei… - Gut …, 2022 - Taylor & Francis
As Helicobacter pylori management has become more challenging and less efficient over
the last decade, the interest in innovative interventions is growing by the day. Probiotic co …

[HTML][HTML] Vonoprazan triple and dual therapy for Helicobacter pylori infection in the United States and Europe: randomized clinical trial

WD Chey, F Mégraud, L Laine, LJ López, BJ Hunt… - Gastroenterology, 2022 - Elsevier
Background & aims Novel, effective treatments for Helicobacter pylori infection are needed.
This study evaluated the efficacy of vonoprazan, a potassium-competitive acid blocker, vs …

Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis

T Rokkas, JP Gisbert, P Malfertheiner, Y Niv… - Gastroenterology, 2021 - Elsevier
Background & Aims A number of double, triple, and quadruple therapies have been
proposed as first-line empiric treatments for Helicobacter pylori infection. However …

Helicobacter pylori world gastroenterology organization global guideline

P Katelaris, R Hunt, F Bazzoli, H Cohen… - Journal of clinical …, 2023 - journals.lww.com
Helicobacter pylori remains a major health problem worldwide, causing considerable
morbidity and mortality due to peptic ulcer disease and gastric cancer. The burden of …

Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

P Malfertheiner, F Megraud, T Rokkas, JP Gisbert… - Gut, 2022 - gut.bmj.com
Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and meta-analysis

JJC Ho, M Navarro, K Sawyer… - Official journal of the …, 2022 - journals.lww.com
METHODS: Ovid MEDLINE, Embase, CINAHL, and Cochrane CENTRAL databases were
searched for manuscripts and conference abstracts published between 2011 and 2021 …

The Ideal Helicobacter pylori Treatment for the Present and the Future

S Suzuki, C Kusano, T Horii, R Ichijima, H Ikehara - Digestion, 2022 - karger.com
Background: Helicobacter pylori eradication treatments are widely performed to improve
gastric mucosal inflammation, promote ulcer healing, and reduce the incidence of gastric …

Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori …

L Bujanda, OP Nyssen, D Vaira, IM Saracino, G Fiorini… - Antibiotics, 2021 - mdpi.com
Background: Bacterial antibiotic resistance changes over time depending on multiple
factors; therefore, it is essential to monitor the susceptibility trends to reduce the resistance …

[HTML][HTML] Primer for development of guidelines for Helicobacter pylori therapy using antimicrobial stewardship

DY Graham, JM Liou - Clinical Gastroenterology and Hepatology, 2022 - Elsevier
We provide a primer to assist in the difficult transition of Helicobacter pylori therapy
guidelines to those that adhere to the principles of antimicrobial stewardship. This transition …